All news

Thermo Fisher rises as JPMorgan adds October pick

Alpha Vantage · TradingView · · AI-summarised by FinFlash

Thermo Fisher Scientific shares rose about 1.1% to $662.27 after JPMorgan added the company to its October growth selections. Second-quarter results showed revenue climbing 10% and operating income up 14%, signaling improved profitability. Analysts maintain a Buy/Hold/Sell split of 22/5/1, with an average target of $652.85, slightly below the current price. Sustained organic growth and margin gains remain key for investor confidence.

Read original source

TMO company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.